We are live on ! Find out more
T. Rowe Price Associates

T. Rowe Price Associates Portfolio holdings

AUM $865B
1-Year Est. Return 30.76%
 

T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.

This Fund
S&P 500
This Quarter Est. Return
+1.52%
1 Year Est. Return
+30.76%
3 Year Est. Return
+117.39%
5 Year Est. Return
+143.85%
10 Year Est. Return
+1,089.89%
AUM
$486B
AUM Growth
+$2.12B
Cap. Flow
+$867M
Cap. Flow %
0.18%
Top 10 Hldgs %
13.96%
Holding
2,615
New
76
Increased
1,051
Reduced
777
Closed
79

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$3.76B
2
CI icon
Cigna
CI
+$1.44B
3
BMY icon
Bristol-Myers Squibb
BMY
+$1.26B
4
OXY icon
Occidental Petroleum
OXY
+$763M
5
DHR icon
Danaher
DHR
+$762M

Sector Composition

Rank Sector Weight
1 Healthcare 22.87%
2 Financials 13.64%
3 Consumer Discretionary 13.54%
4 Industrials 10.67%
5 Technology 10.39%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SUSQ
1726
DELISTED
SUSQUEHANNA BANCSHARES INC
SUSQ
$1.02M ﹤0.01%
72,418
DHC
1727
Diversified Healthcare Trust
DHC
$2.02B
$1.02M ﹤0.01%
58,738
GEO icon
1728
The GEO Group
GEO
$4.14B
$1.02M ﹤0.01%
44,726
+3,150
+8% +$81.2K
FMER
1729
DELISTED
FIRSTMERIT CORP
FMER
$1.02M ﹤0.01%
48,876
+6,500
+15% +$129K
ADEA icon
1730
Adeia
ADEA
$3.1B
$1.01M ﹤0.01%
100,775
MENT
1731
DELISTED
Mentor Graphics Corp
MENT
$999K ﹤0.01%
37,780
H icon
1732
Hyatt Hotels
H
$16.8B
$998K ﹤0.01%
17,600
THG icon
1733
Hanover Insurance
THG
$7.74B
$993K ﹤0.01%
13,420
TIME
1734
DELISTED
Time Inc.
TIME
$992K ﹤0.01%
43,130
+6,800
+19% +$155K
BYD icon
1735
Boyd Gaming
BYD
$6.03B
$991K ﹤0.01%
66,300
+7,600
+13% +$107K
MDP
1736
DELISTED
Meredith Corporation
MDP
$991K ﹤0.01%
19,000
+4,300
+29% +$228K
ENZY
1737
DELISTED
Enzymotec Ltd
ENZY
$985K ﹤0.01%
304,445
-68,445
-18% -$628K
HTD
1738
John Hancock Tax-Advantaged Dividend Income Fund
HTD
$905M
$983K ﹤0.01%
50,000
SITC icon
1739
SITE Centers
SITC
$156M
$983K ﹤0.01%
49,360
TCRT icon
1740
Alaunos Therapeutics
TCRT
$4.88M
$982K ﹤0.01%
545
+210
+63% +$326K
LGF
1741
DELISTED
Lions Gate Entertainment
LGF
$982K ﹤0.01%
26,500
+2,700
+11% +$90.1K
HE icon
1742
Hawaiian Electric Industries
HE
$2.06B
$978K ﹤0.01%
32,900
CIM
1743
Chimera Investment
CIM
$991M
$965K ﹤0.01%
23,460
ABG icon
1744
Asbury Automotive
ABG
$3.76B
$964K ﹤0.01%
10,640
+1,300
+14% +$113K
CTB
1745
DELISTED
Cooper Tire & Rubber Co.
CTB
$964K ﹤0.01%
28,500
MORN icon
1746
Morningstar
MORN
$7.41B
$963K ﹤0.01%
12,100
FCRD
1747
DELISTED
First Eagle Alternative Capital BDC, Inc. Common Stock
FCRD
$960K ﹤0.01%
83,100
-6,000
-7% -$73.4K
HDS
1748
DELISTED
HD Supply Holdings, Inc.
HDS
$960K ﹤0.01%
27,300
MCY icon
1749
Mercury Insurance
MCY
$5.84B
$957K ﹤0.01%
17,193
+1,700
+11% +$95.7K
TGI
1750
DELISTED
Triumph Group
TGI
$957K ﹤0.01%
14,500

Similar funds

T. Rowe Price Associates's Q2 2015 Portfolio in Review

As of Q2 2015, T. Rowe Price Associates held 2,615 positions worth $486B, up 0.44% from $484B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

T. Rowe Price Associates's Q2 2015 filing shows 76 new, 1,051 increased, 777 reduced and 79 closed positions. Its largest new stake was Allergan plc: 548,825 shares worth $570M. The largest sale was PHARMACYCLICS INC, an estimated $2.46B.

By sector, the portfolio is most concentrated in Healthcare at 23% of assets, up from 21% a quarter earlier, followed by Financials and Consumer Discretionary.

  • T. Rowe Price Associates's largest Q2 2015 buy was Allergan plc: 548,825 shares worth $570M.
  • T. Rowe Price Associates added most to Microsoft in Q2 2015, an estimated $3.76B increase.
  • T. Rowe Price Associates's biggest Q2 2015 reduction was Wynn Resorts, cutting an estimated $1.11B.
  • T. Rowe Price Associates fully exited PHARMACYCLICS INC in Q2 2015, selling an estimated $2.46B.
  • T. Rowe Price Associates's ten largest holdings make up 14% of its $486B portfolio in Q2 2015.
  • T. Rowe Price Associates opened 76 new positions and closed 79 in Q2 2015.
  • T. Rowe Price Associates's portfolio value rose 0.44% quarter-over-quarter to $486B.

Based on T. Rowe Price Associates's 13F filing for Q2 2015, filed 14 Aug 2015.